Cobram Estate Olives (CBO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
30 Oct, 2026Opening remarks and agenda
Meeting opened with quorum; agenda covered FY26 results, commercial and operational updates, COR integration, formal business, questions and close.
Chair’s written address and meeting recording were to be released through ASX and the website.
Financial performance review
FY26 normalised EBITDA was $61.4m, down from $116.6m in FY25; two-year rolling normalised EBITDA rose 0.3% to $90.9m.
Revenue was $315.5m versus $335.5m; normalised EBT was $13.0m versus $76.1m, while reported net loss after tax was $4.2m.
Packaged goods sales rose 16.8% to $253.2m; Australian sales grew 1.6% to $165.7m and U.S. sales rose 63.1% to $87.5m, including three months of COR sales.
Operating cash flow before interest and tax was $47.5m versus $83.0m; net assets were $517.6m and net debt was $437.3m at 30 June 2026.
FY26 Australian harvest was a record off-year at 11.1m litres, 10% above the previous off-year; oil content was 15% below average, with an estimated $20m–$25m EBITDA impact versus average conditions.
Board and executive committee updates
Daniel Masters was elected Non-Executive Director; he cited experience investing in 25 U.S. family businesses and expertise in growth and markets.
Craig Ball was re-elected Non-Executive Director for his final term; he cited the team’s ability to manage challenges and execute COR integration.
Rob McGavin served as Non-Executive Chair and Co-Founder; Leandro Ravetti and Sam Beaton served as Joint CEOs and Executive Directors, responsible for technical/production and finance/commercial, respectively.
New U.S. CFO and Chief Commercial Officer appointments strengthened the enlarged U.S. business; Ravetti relocated to the U.S. to lead integration work.
Latest events from Cobram Estate Olives
- COR acquisition drives U.S. growth; FY27 EBITDA and cash flow set to rise significantly.CBO
H2 2026 - EBITDA ahead of guidance, net loss widened, capital raised for U.S. expansion and acquisition.CBO
H1 2026 - Record profit, U.S. expansion, and sustainability drive long-term growth and shareholder value.CBO
AGM 2025 - Major capital raise to fund rapid USA expansion, targeting 3,600 hectares and 9M+ litres of oil.CBO
Investor Presentation - Record profit, strong sales growth, and U.S. expansion mark a transformative year.CBO
H2 2025 - Record sales, profit, and growth initiatives drive a positive outlook.CBO
AGM 2024 - Sales and profit surged, with strong growth in Australia and the USA and a positive FY2025 outlook.CBO
H2 2024 - Sales and EBITDA surged, led by packaged goods and U.S. expansion, with a strong FY2025 outlook.CBO
H1 2025